Clinical Trials Directory

Trials / Completed

CompletedNCT02851316

Whole Body Vibration on Running Biomechanics

The Effect of Whole Body Vibration on Running Biomechanics in Individuals With Anterior Cruciate Ligament Reconstruction

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
California State University, Fullerton · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Not accepted

Summary

Whole body vibration (WBV) acutely improves quadriceps strength, and may improve long-term outcomes in individuals with anterior cruciate ligament reconstruction (ACLR). However, it is unclear if WBV influences athletic tasks such as running. The purpose of this study is to evaluate the influence of WBV on running biomechanics in individuals with ACLR.

Detailed description

Individuals with anterior cruciate ligament reconstruction (ACLR) have deficits in quadriceps muscles function that influences walking and running biomechanics. In the long term, alterations in walking and running contribute to physical disability and the development of knee osteoarthritis. Unfortunately, rehabilitation for the quadriceps muscles is often ineffective, and novel strategies to improve rehabilitation efforts are needed. Whole body vibration (WBV) acutely improves quadriceps strength, and may improve long-term outcomes in individuals with ACLR. However, it is unclear if WBV influences athletic tasks such as running. Specific Aim 1: The purpose of this study is to determine the effect of WBV on running biomechanics in individuals with ACLR. The investigators hypothesize that WBV will improve running characteristics associated with knee osteoarthritis development.

Conditions

Interventions

TypeNameDescription
OTHERWhole Body VibrationParticipants will stand in a squatted position on a platform that provides a brief vibratory stimuli.

Timeline

Start date
2016-07-01
Primary completion
2017-09-01
Completion
2017-09-01
First posted
2016-08-01
Last updated
2019-08-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02851316. Inclusion in this directory is not an endorsement.